Next up in our notes from Invest For Kids Chicago 2013 is Mark Kingdon of Kingdon Asset Management. He pitched two ideas: Aegerion Pharma (AEGR) and Boeing (BA).
Mark Kingdon's Presentation at Invest For Kids Chicago
• $1.6 million dollars 30 years ago; 17% CAGR 30 years
• Generally positive view on global economy and equities
• Increasing auto and housing outlook
• Special situations:
• Idea #1: Aegerion Pharma (AEGR)
• Drug is Juxtapid
• Orphan drug for HOHF (ultra high cholesterol)
• Original thought was 300 patients in US and 900 worldwide
• Actually though TAM of 15,000 patients or more (no pediatric assumed)
• $295,000 per year per patient leads to $25 EPS
• Sell side is now upping patient forecast to 15,000
• Upcoming testing in children, Japan is growing
• Idea #2: Boeing (BA): thinks it's undervalued
• 5 years late and well over budget
• First major plans designed from ground up since 1960’s
• Terrific customer experience and better for carriers
• 787 is very economical to operate
• (no rivets rather using special glue)
• Boeing CEO – payback could be as low as two years.
• Used to be 5% payback on a plane and now expected return is 30%
• Airline industry is facing rising demand
• 8 year backlog for planes
• 2015 is mid-cycle
• 12 FCF (low end of 2015) x 14 multiple = 156 stock
• Boeing has promised to return 80% of FCF to shareholders
• Multiple should rise, backlog is strong
Check out the rest of the hedge fund presentations from Invest For Kids Chicago here.
Wednesday, October 30, 2013
Mark Kingdon's Thesis on Boeing & Aegerion Pharma: Invest For Kids Chicago
blog comments powered by Disqus